# Mechanistic Characterization of Uterine Pain

> **NCT04145518** · PHASE4 · COMPLETED · sponsor: **Endeavor Health** · enrollment: 183 (actual)

## Conditions studied

- Dysmenorrhea (Disorder)
- Dysmenorrhea Primary
- Dysmenorrhea Secondary
- Endometrial Diseases
- Leiomyoma
- Fibroid Uterus

## Interventions

- **DRUG:** Naproxen Sodium

## Key facts

- **NCT ID:** NCT04145518
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-25
- **Primary completion:** 2025-07-23
- **Final completion:** 2025-07-23
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04145518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04145518, "Mechanistic Characterization of Uterine Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04145518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*